Longeveron Inc., a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, announced that the Company’s...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Mabtech and Sai Life Sciences announced a strategic collaboration that designates Sai’s Boston laboratory as a co-marketed U.S. execution and demonstration hub for the...
